Health Law & Business

Dynavax Says Covid-19 Vaccine Trial Could Start as Soon as July

May 18, 2020, 9:11 PM

Dynavax Technologies sees one or more of its collaboration partners commence a Phase 1 clinical trial of a potential COVID-19 vaccine as soon as July 2020.

  • Co. to provide an update on its early-stage collaborations regarding the potential development of a vaccine for COVID-19 on May 19
  • Co. shares up about 20% post-market

To view the source of this information click here

To contact the reporter on this story:
Cara Moffat in Los Angeles at cmoffat@bloomberg.net

To contact the editor responsible for this story:
Lauren Berry at lberry4@bloomberg.net

© 2020 Bloomberg L.P. All rights reserved. Used with permission.

To read the full article log in. To learn more about a subscription click here.